Your browser doesn't support javascript.
loading
Evaluation of GLUT1, IGF-2, VEGF, FGF 1, and angiopoietin 2 in infantile hemangioma.
Aydin Köker, Sultan; Kömüroglu, Ahmet Ufuk; Köksoy, Adem Yasin; Siraz, Ülkü Gül; Tekin, Emine; Köker, Alper.
Affiliation
  • Aydin Köker S; Department of Pediatric Hematology and Oncology, SBÜ Van Education and Research Hospital, Van, Turkey. Electronic address: drsultanaydin@hotmail.com.
  • Kömüroglu AU; Department of Biochemistry, Yüzüncü Yil University, Van, Turkey.
  • Köksoy AY; Department of Pediatrics, SBÜ Van Education and Research Hospital, Van, Turkey.
  • Siraz ÜG; Department of Pediatrics, SBÜ Van Education and Research Hospital, Van, Turkey.
  • Tekin E; Department of Pediatrics, SBÜ Van Education and Research Hospital, Van, Turkey.
  • Köker A; Department of Pediatric Intensive Unit, Hatay State Hospital, Van, Turkey.
Arch Pediatr ; 28(4): 296-300, 2021 May.
Article in En | MEDLINE | ID: mdl-33715934
ABSTRACT

INTRODUCTION:

Infantile hemangioma (IH) is a common vascular tumor in children. It is reported that IHs are associated with immunochemical markers such as vascular endothelial growth factor (VEGF)-A, glucose transporter isoform 1 (GLUT1), and insulin-like growth factor-2 (IGF-2). MATERIAL AND

METHODS:

This cross-sectional study focused on pediatric patients with IH. A total of 46 patients (mean age 14.2±21.9 months) with IH and 45 healthy controls (mean age 21.8±15.08 months) were enrolled. Demographic data, clinical findings, and laboratory parameters were recorded. Blood samples were collected. Serum GLUT1, IGF-2, VEGF-A, fibroblast growth factor 1 (FGF1), and angiopoietin 2 levels were assessed by enzyme-linked immunosorbent assay.

RESULTS:

Serum GLUT1, IGF-2, and VEGF-A levels were significantly higher in patients with IH than in healthy controls (8.80±4.07pg/mL vs. 5.66±4.34pg/mL, 281.10±84.12pg/mL vs. 234.19±75.38pg/mL, 1196.99±389.34pg/mL vs. 996.99±349.16pg/mL, respectively, p=0.026, p=0.030, and p=0.036). Serum GLUT1, IGF-2, and VEGF-A levels in patients with complicated hemangioma were significantly higher than in healthy controls (9.69±3.94pg/mL vs. 5.66±4.34pg/mL, 289.94±83.18pg/mL vs. 234.19±75.38pg/mL, 1276.22±388.24pg/mL vs. 996.99±349.16pg/mL, respectively, p=0.017, p=0.022, and p=0.011). Serum GLUT1, IGF-2, and VEGF-A levels in patients with hemangioma receiving propranolol treatment were significantly higher than in healthy controls. Serum FGF1 levels were higher in patients with IH, complicated hemangioma, and hemangioma receiving propranolol treatment than in healthy controls but the difference was not statistically significantly.

CONCLUSION:

Serum GLUT1, IGF-2, and VEGF-A levels were positively correlated with disease severity in patients with hemangioma, for example, in complicated hemangioma and hemangioma requiring propranolol treatment. However, further research on larger and different age subgroups is warranted to assess these markers.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Propranolol / Insulin-Like Growth Factor II / Fibroblast Growth Factor 1 / Vascular Neoplasms / Angiopoietin-2 / Vascular Endothelial Growth Factor A / Glucose Transporter Type 1 / Hemangioma Type of study: Observational_studies / Prevalence_studies / Risk_factors_studies Limits: Child / Child, preschool / Humans / Infant / Male Language: En Journal: Arch Pediatr Year: 2021 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Propranolol / Insulin-Like Growth Factor II / Fibroblast Growth Factor 1 / Vascular Neoplasms / Angiopoietin-2 / Vascular Endothelial Growth Factor A / Glucose Transporter Type 1 / Hemangioma Type of study: Observational_studies / Prevalence_studies / Risk_factors_studies Limits: Child / Child, preschool / Humans / Infant / Male Language: En Journal: Arch Pediatr Year: 2021 Document type: Article